Healthcare Consumption Decreases in Parallel with Improvements in Quality of Life during GH Replacement in Hypopituitary Adults with GH Deficiency
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The morbidity associated with GH deficiency (GHD) in adults is now well established. Furthermore, many controlled clinical trials have demonstrated the efficacy of GH replacement therapy. The aim of the present study was to determine whether the effects of GH replacement in adults are reflected in a reduced use of healthcare resources, in addition to improving quality of life (QoL). Data concerning visits to the doctor, number of days in hospital, and amount of sick leave were obtained from patients included in KIMS (Pharmacia International Metabolic Database), a large pharmacoepidemiological survey of hypopituitary adults with GHD, for 6 months before GH treatment and for 6-12 months after the start of treatment. Assistance required with normal daily activities was recorded at baseline and after 12 months of GH therapy. QoL (assessed using a disease-specific questionnaire, QoL-Assessment of GHD in Adults) and satisfaction with physical activity during leisure time were also assessed. For the total group (n = 304), visits to the doctor, number of days in hospital, and amount of sick leave decreased significantly (P < 0.05) after 12 months of GH therapy. Patients also needed less assistance with daily activities, although this was significant (P < 0.01) only for the men. QoL improved after 12 months of GH treatment (P < 0.001), and both the amount of physical activity and the patients' satisfaction with their level of physical activity improved after 12 months (P < 0.001). In conclusion, GH replacement therapy, in previously untreated adults with GHD, produces significant decreases in the use of healthcare resources, which are correlated with improvements in QoL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Approximate Distribution of Estimates of Variance Components
Satterthwaite, F. E. (1946) · Biometrics Bulletin · doi:10.2307/3002019 · Cited by 4,373
Salomon, F., Cuneo, R. C., Hesp, R., & Sönksen, P. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912283212605 · Cited by 1,326
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review
Carroll, P. V., Christ the members of Growth Hormon, E. R., Bengtsson, B. Å., Carlsson, L., Christiansen, J. S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4594 · Cited by 822
Self-citationQuality of Life of Adults with Growth Hormone Deficiency: a Controlled Study
BJORK, S., JONSSON, B., WESTPHAL, O., & LEVIN, J. ‐. (1989) · Acta Paediatrica · doi:10.1111/j.1651-2227.1989.tb11242.x · Cited by 135
Span, J. P. T., Pieters, G. F. F. M., Sweep, C. G. J., Hermus, A. R. M. M., & Smals, A. G. H. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6463 · Cited by 132
Cost of illness in adult patients with hypopituitarism
Ehrnborg, C., Hakkaart-Van Roijen, L., Jonsson, B., Rutten, F. F. H., Bengtsson, B.-?., & Ros??n, T. (2000) · PharmacoEconomics · doi:10.2165/00019053-200017060-00008 · Cited by 47
Self-citationThe burden of illness of hypopituitary adults with growth hormone deficiency
Hakkaart-van Roijen, L., Beckers, A., Stevenaert, A., & Rutten, F. F. H. (1998) · PharmacoEconomics · doi:10.2165/00019053-199814040-00006 · Cited by 33
Cited by
Abs, R., Mattsson, A. F., Bengtsson, B.-Å., Feldt-Rasmussen, U., Góth, M. I., Koltowska-Häggström, M., Monson, J. P., Verhelst, J., & Wilton, P. (2005) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2005.06.018 · Cited by 91
Self-citationRagnarsson, O., Mattsson, A. F., Monson, J. P., Filipsson Nyström, H., Åkerblad, A.-C., Kołtowska-Häggström, M., & Johannsson, G. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0397 · Cited by 46
Jeong, J. H., Kim, Y. Z., Cho, Y. W., & Kim, J. S. (2010) · Journal of Neurosurgery · doi:10.3171/2009.10.jns091152 · Cited by 32
Klose, M., Jonsson, B., Abs, R., Popovic, V, Koltowska-Häggström, M., Saller, B., Feldt-Rasmussen, U., & Kourides, I. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0328 · Cited by 31
Self-citationHolmer, H., Svensson, J., Rylander, L., Johannsson, G., Rosén, T., Bengtsson, B.-Å., Thorén, M., Höybye, C., Degerblad, M., Bramnert, M., et al. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.09.008 · Cited by 16
Self-citation
Metadata
- Authors
- Hernberg-Ståhl, E., Luger, A., Abs, R., Bengtsson, B.-Å., Feldt-Rasmussen, U., Wilton, P., Westberg, B., & Monson, J. P.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2001-11
- Volume
- 86
- Issue
- 11
- Pages
- 5277-5281
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1984036348
- Cited by
- 76
- References
- 7
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Healthcare Consumption Decreases in Parallel with Improvements in Quality of Life during GH Replacement in Hypopituitary Adults with GH Deficiency. https://app.cochat.ai/papers/10.1210/jcem.86.11.7997
- The paper
- Hernberg-Ståhl, E., Luger, A., Abs, R., Bengtsson, B.-Å., Feldt-Rasmussen, U., Wilton, P., Westberg, B., & Monson, J. P. (2001). Healthcare Consumption Decreases in Parallel with Improvements in Quality of Life during GH Replacement in Hypopituitary Adults with GH Deficiency. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem.86.11.7997
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.